Your browser doesn't support javascript.
loading
Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer.
Nasca, Vincenzo; Barretta, Francesco; Corti, Francesca; Lonardi, Sara; Niger, Monica; Elez, Maria Elena; Fakih, Marwan; Jayachandran, Priya; Shah, Aakash Tushar; Salati, Massimiliano; Fenocchio, Elisabetta; Salvatore, Lisa; Cremolini, Chiara; Ros, Javier; Ambrosini, Margherita; Mazzoli, Giacomo; Intini, Rossana; Overman, Michael J; Miceli, Rosalba; Pietrantonio, Filippo.
Afiliación
  • Nasca V; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale dei Tumori, Milano, Italy.
  • Barretta F; Unit of Clinical Epidemiology and Trial Organization, IRCCS Fondazione Istituto Nazionale dei Tumori, Milano, Italy.
  • Corti F; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale dei Tumori, Milano, Italy.
  • Lonardi S; Department of Medical Oncology, Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy.
  • Niger M; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale dei Tumori, Milano, Italy.
  • Elez ME; Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Fakih M; Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center Duarte, Duarte, California, USA.
  • Jayachandran P; Oncology, University of Southern California, Los Angeles, California, USA.
  • Shah AT; Baylor College of Medicine, Houston, Texas, USA.
  • Salati M; Department of Medical Oncology, University Hospital Modena, Modena, Italy.
  • Fenocchio E; Multidisciplinary Outpatient Oncology Clinic, Candiolo Cancer Institute, Candiolo, Italy.
  • Salvatore L; Oncologia Medica, Università Cattolica del Sacro Cuore, Roma, Italy.
  • Cremolini C; Cancer Comprehensive Center, IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy.
  • Ros J; Unit of Medical Oncology 2, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
  • Ambrosini M; Medical Oncology, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Mazzoli G; Hospital Vall Hebron, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Intini R; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale dei Tumori, Milano, Italy.
  • Overman MJ; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale dei Tumori, Milano, Italy.
  • Miceli R; Department of Oncology, IRCCS Istituto Oncologico Veneto, Padova, Italy.
  • Pietrantonio F; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
J Immunother Cancer ; 11(1)2023 01.
Article en En | MEDLINE | ID: mdl-36593068
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Neoplasias del Colon Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Neoplasias del Colon Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Italia